Who Owns SGMT?

Sagimet Biosciences Inc. — Institutional Ownership & 13F Holdings

$8.14

-0.45 (-5.23%)

Market Cap

$166.8M

Shares Outstanding

32,017,612

Institutional Holders

70

Total Inst. Value

$44.9M

% of Float Held

QoQ Holder Change

+1

Institutional data as of Q1 2025

New Positions

23

Closed Positions

14

Increased

15

Decreased

18

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Point72 Asset Management, L.P.$5.7M1,755,143
2Blue Owl Capital Holdings LP$4.3M1,328,351
3Alyeska Investment Group, L.P.$3.9M1,192,443
4VANGUARD GROUP INC$3.8M1,153,856
5BlackRock, Inc.$3.2M970,824
6BAKER BROS. ADVISORS LP$3.1M952,996
7Rock Springs Capital Management LP$2.6M787,808
8HHLR ADVISORS, LTD.$2.4M724,800
9Siren, L.L.C.$2.4M724,771
10PFM Health Sciences, LP$2.1M649,006

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold SGMT?

As of Q1 2025, 70 institutional investors report holding SGMT (Sagimet Biosciences Inc.) in their 13F filings.

Which hedge fund owns the most SGMT?

The largest institutional holder of SGMT is Point72 Asset Management, L.P. with $5.7M in shares.

Are institutions buying or selling SGMT?

This quarter, 23 institutions opened new positions in SGMT and 14 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.